medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 6

Next >>

Rev Invest Clin 2017; 69 (6)

Chikungunya: Molecular Aspects, Clinical Outcomes and Pathogenesis

Bautista-Reyes E, Núñez-Avellaneda D, Alonso-Palomares LA, Salazar MI

Language: English
References: 72
Page: 299-307
PDF size: 401.04 Kb.


ABSTRACT

The alarming worldwide emergence of the chikungunya virus began in the last decade. Since the first autochthonous transmission in Mexico in November of 2014, the virus has spread throughout the country, resulted in multiple outbreaks. This virus produces an acute and self-limiting disease characterized by fever, polyarthralgia, myalgia, exanthema, and general malaise. It is transmitted to humans by the bite of Aedes aegypti and A. albopictus mosquitoes. The fact that the clinical presentation is similar to that produced by other arboviruses complicates its clinical diagnosis. The chronic stage of the disease can cause severe consequences lasting months or years, from local arthralgia to rheumatoid arthritis. In this review, we emphasize the public health threat posed by this highly disabling emerging disease, the clinical outcomes, and its possible physiopathological process. We outline the diagnosis and the impact that this virus has had in Mexico since its introduction.


REFERENCES

  1. Kariuki M, Nderitu L, Ledermann JP, et al. Tracking epidemic chikungunya virus into the Indian Ocean from East Africa. J Gen Virol. 2008;89:2754-60.

  2. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263.

  3. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 2008;5:e60.

  4. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis. 2007;7: 306-7.

  5. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, Lamballiere X. Chikungunya in the Americas. Lancet. 2014;383:514.

  6. Weaver SC. Arrival of Chikungunya virus in the New World: Prospects for spread and impact on public health. PLoS Negl Trop Dis. 2014;8:e2921.

  7. Morens D, Fauci AS. Chikungunya at the door - déjà vu all over again? N Engl J Med. 2014;371:885-7.

  8. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;2:e201.

  9. Kautz TF, Díaz-González EE, Erasmus JH, et al. Chikungunya virus as cause of febrile illness outbreak, Chiapas, Mexico, 2014. Emerg Infect Dis. 2015;21:2070-3.

  10. Díaz-González EE, Kautz TF, Dorantes-Delgado A, et al. First report of Aedes aegypti transmission of chikungunya virus in the Americas. Am J Trop Med Hyg. 2015;93:1325-9.

  11. Díaz-Quiñonez JA, Escobar-Escamilla N, Ortíz-Alcántara J, et al. Identification of Asian genotype of chikungunya virus isolated in Mexico. Virus Genes. 2016;52:127-9.

  12. Cigarroa-Toledo N, Blitvich BJ, Cetina-Trejo RC, et al. Chikungunya virus in febrile humans and Aedes aegypti mosquitoes, Yucatan, Mexico. Emerg Infect Dis. 2016;22:1804-7.

  13. Fernández-Salas I, Díaz-González EE, López-Gatell H, Alpuche-Aranda CM. Chikungunya and zika virus dissemination in the Americas: different arbovirus reflecting the same spreading routes and poor vector-control policies. Curr Opin Infect Dis. 2016;29: 467-75.

  14. Solignat M, Gay B, Higgs S, Briant L, Devaux C. Replication cycle of chikungunya: A re-emerging arbovirus. Virol J. 2009;393:183-97.

  15. Tsetsarkin KA, Chen R, Sherman MB, Weaver SC. Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol. 2011;1:310-7.

  16. Sumathy K, Ella KM. Genetic diversity of Chikungunya virus, India 2006-2010: Evolutionary dynamics and serotype analyses. J Med Virol. 2012;84:462-70.

  17. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010;8:491-500.

  18. Staples JE, Powers A, Tomashek K, et al. Preparación y respuesta ante la eventual introducción del virus chikungunya en las Américas. Washington, D.C. CDC/OPS (2011). ISBN: 978-92- 75-31632-0.

  19. Thiberville SD, Boisson V, Gaudart J, Simon F, Flahault A, Lamballerie X. Chikungunya fever: A clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis. 2013;7:e2004.

  20. Wintachai P, Wikan N, Kuadkitkan A, et al. Identification of prohibitin as a Chikungunya virus receptor protein. J Med Virol. 2012;84:1757-70.

  21. Kathiria AS, Burcher LD, Feagins LA, Souza RF, Boland R, Theiss AL. Phohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One. 2012;7:e31231.

  22. Powers AM, Logue CH. Changing patterns of chikungunya virus: Re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88: 2363-77.

  23. Lum FM, Teo TH, Lee WW, Kam YM, Rénia L, Ng LF. An essential role of antibodies in the control of chikungunya virus infection. J Immunol. 2013;190:6295-302.

  24. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C. Chikungunya virus infection. Curr Infect Dis Rep. 2011;13:218-28.

  25. Thiberville S, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99:345-70.

  26. Gasque P, Couderc T, Lecuit M, Roques P, Ng LF. Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis. 2015;15:241-9.

  27. Van Dujil-Richter MK, Horrnweg TE, Rodenhuis-Zybert IA, Smit JM. Early events in chikungunya virus infection-from virus cell binding to membrane fusion. Viruses. 2015;7:3647-74.

  28. Gérardin P, Fianu A, Michault A, et al. Predictors of chikungunya rheumatism: A prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15:R9.

  29. Burt FJ, Ralph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet 2012;379:662-71.

  30. Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Réunion Island: Early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401-7.

  31. Lakshmi V, Meeraja M, Sunnalaxmi MV, et al. Clinical features and molecular diagnosis of chikungunya fever from South India. Clin Infect Dis. 2008;46:1436-42.

  32. Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: A review. J Ophthalmic Inflamm Infect. 2013;3:35.

  33. Lemant J, Boisson V, Winer A, et al. Serious acute chikungunya virus infection requiring intensive care during the Réunion Island outbreak in 2005-2006. Crit Care Med. 2008;36:2536-41.

  34. Economopoulou A, Dominguez M, Helynck B, et al. Atypical chikungunya virus infections: Clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2009;137:534-41.

  35. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profile of Chikungunya in infants. Indian J Pediatr. 2009;76:151-5.

  36. Nkoghe D, Kassa RF, Caron M, et al. Clinical forms of chikungunya in Gabon, 2010. PLoS Negl Trop Dis. 2012;6:e1517.

  37. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr. 2009;76:185-9.

  38. Le Bomin A, Hebert JC, Marty P, Delaunay P. [Confirmed chikungunya in children in Mayotte. Description of 50 patients hospitalized from February to June 2006]. Med Trop (Mars). 2008;68: 491-5.

  39. Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008;23:1028-35.

  40. Lewthwaite P, Vasanthapuram R, Osborne JC, et al. Chikungunya virus and central nervous system infections in children, India. Emerg Infect Dis. 2009;15:329-31.

  41. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marioutou C. Chikungunya infection: An emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore). 2007;86:123-37.

  42. Borgherini G, Poubeau P, Staikowsky F, et al. Persistent arthralgia associated with chikungunya virus: A study of 88 adult patients on Reunion island. Clin Infect Dis. 2008;47:469-75.

  43. Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic chikungunya disease on Reunion Island: Course of rheumatic manifestations and associated factors over a 15- month period. PLoS Negl Trop Dis. 2009;3:e389.

  44. Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Tran R Soc Trop Med Hyg. 2010;104:392-9.

  45. Schilte C, Staikovsky F, Couderc T, et al. Chikungunya virusassociated long-term arthralgia: A 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7:e2137.

  46. Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: Case report and review of the literature. Semin Arthritis Rheum. 2013;43:273-8.

  47. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: A 2-year prospective rural community study. Epidemiol Infect. 2012;140:842-50.

  48. Moro ML, Grilli E, Corvetta A, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect. 2012;65:165-72.

  49. Mohd-Zim MA, Sam IC, Syed-Omar SF, Chan YF, AbuBakar S, Kamarulzaman A. Chikungunya infection in Malaysia: Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol. 2013;56:141-5.

  50. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200.

  51. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009;76:654-7.

  52. Marimoutou C, Vivier E, Oliver M, Boutin JP, Simon F. Morbidity and impaired quality of life 30 months after chikungunya infection: Comparative cohort of infected and uninfected French military policemen in Réunion Island. Medicine (Baltimore). 2012;91: 212-19.

  53. Couturier E, Guillemin F, Mura M, et al. Impaired quality of life after chikungunya virus infection: A 2-year follow-up study. Rheumatology (Oxford). 2012;51:1315-22.

  54. Hoarau JJ, Jaffar-Bandjee MC, Krejbich-Trotot P, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184:5914-27.

  55. Kam Y, Simarmata D, Chow A, et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012;205:1147-54.

  56. Shenoy S, Pradeep GC. Neurodevelopmental outcome of neonates with vertically transmitted chikungunya fever with encephalopathy. Indian Pediatr. 2012;49:238-40.

  57. Ramful D, Sampériz S, Fritel X, et al. Antibody kinetics in infants exposed to chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis. 2014;209:1726-30.

  58. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998;52:943-51.

  59. Walsh NC, Reinwald S, Manning CA, et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009;24:1572-85.

  60. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis. Nature. 1999;397:315-23.

  61. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13: 2412-24.

  62. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-19.

  63. Horwood NJ, Elliot J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 1998;139:4743-6.

  64. Chopra A, Anuradha V, Lagoo-Joshin V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58:2921-2.

  65. Phuklia W, Kasisith J, Modhiran N, et al. Osteoclastogenesis induced by CHIKV- infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res. 2013; 177:179-88.

  66. Chen W, Foo S-S, Sims NA, Herrero LJ, Walsh NC, Mahalingam S. Arthritogenic alphavirus: new insights into arthritis and bone pathology. Micro. 2015;234:35-43.

  67. Chow A, Zhishenng H, Ong EK, et al. Persistent arthralgia induced by chikungunya virus infection is associated with interleukin- 6 and granulocyte macrophage colony stimulating factor. J Infect Dis. 2011;203:149-57.

  68. Ng LF, Chow A, Sun Y-J, et al. IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One. 2009;4:e4261.

  69. Noret M, Herrero L, Rulli N, et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis. 2012;206:455-7.

  70. Lindbury BA, Rulli NE, Suhrbier A, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197:1585-93.

  71. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiquino A, Leroy EM. The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis. 2011;204:115-23.

  72. Teo TH, Lum FM, Claser C, et al. A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J Immunol. 2013;190:259-69.




2020     |     www.medigraphic.com